Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2TH9K
|
|||
| Drug Name |
Immunoxel
|
|||
| Indication | Tuberculosis [ICD-11: 1B10-1B14] | Phase 3 | [1] | |
| Company |
TB
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01061593) Phase III, Double-blind, Placebo-controlled, Randomized, 1-month Clinical Trial of Immunoxel Combined With Anti-TB Therapy Versus Anti-TB Therapy With Placebo. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.